BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for M Beresini

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Lead identification of novel and selective TYK2 inhibitors.EBI
Genentech
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).EBI
Genentech
N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship.EBI
Genentech
N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety.EBI
Genentech
Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory Activity.EBI
Paraza Pharma
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8.EBI
Genentech
Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines.EBI
F. Hoffmann-La Roche
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K).EBI
Genentech
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsBDB
Vtv Therapeutics